Navigation Links
Kessler Foundation implements Ekso Bionics' first commercial robotic exoskeleton

WEST ORANGE, N.J. -- On Monday, Kessler Foundation became the second rehabilitation research center in the U.S. to implement Ekso, a wearable, robotic battery-powered exoskeleton that allows wheelchair users with lower-extremity weakness to stand and walk.

"Kessler Foundation makes strategic investments in innovative technology that have the potential to improve the quality of life of people with disabilities," said Rodger DeRose, president and chief executive officer of Kessler Foundation. "Our partnership with Ekso Bionics confirms our leadership in rehabilitation research."

Made by Ekso Bionics, the new commercial version of Ekso is being distributed to the company's ten charter partnersincluding Kessler Foundation, for further testing. In October 2011, Foundation researchers successfully tested a prototype of Ekso on six participants with spinal cord injuries; five had paraplegia and one had tetraplegia, a higher level of injury. Each took steps in Ekso that were documented on video.

Scientists at Kessler Foundation are looking beyond the gains in mobility to the potential impact of standing and walking on overall health and well being. According to lead investigator Gail Forrest, PhD, they will study the effects on circulation, bone density, muscle strength, cardiac and lung function, mood, and bowel and bladder function. The outlook is promising according to preliminary research data collected for two participants during the October testing week. Protocols will be developed for using the device and identifying who will benefit from its use. Establishing an evidence base for safety and efficacy may support Ekso's use as a therapeutic rehabilitation device for mobility impairments caused by spinal cord injury and other conditions.

Kessler Foundation will collaborate with Kessler Institute for Rehabilitation for the Ekso studies, which will enable researchers and physical therapists to work together to determine best practices. Ekso Bionics plans to market a unit for home use in latter 2013.

Contact: Carolann Murphy
Kessler Foundation

Related biology news :

1. Kessler Foundation neuroscientist Jordan Grafman receives Humboldt Research Award
2. Kessler Foundation tests Ekso exoskeletal device in 6 patients with traumatic spinal cord injury
3. Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation
4. Wayne State-licensed technology receives grant from the Foundation Fighting Blindness
5. National Science Foundation supports research aimed at reducing the use of fertilizer
6. UofL researcher earns the Foundation for Polish Science Prize
7. Elsevier Foundation 2011 grants for women in science and libraries in developing countries
8. National Science Foundation awards major grant to Cary Institute
9. The Michael J. Fox Foundation awards nearly $200,000 to develop novel drugs for Parkinsons disease
10. National Science Foundation makes first awards in Sustainability Research Coordination Program
11. Peggy Lillis Foundation honors Dr. Sherwood Gorbach for career combating C. diff infection
Post Your Comments:
(Date:11/17/2015)... November 17, 2015 Paris ... 2015.  --> Paris , qui ... DERMALOG, le leader de l,innovation biométrique, a inventé ... passeports et empreintes sur la même surface de balayage. ... et l,autre pour les empreintes digitales. Désormais, un seul ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015  Neurocrine ... Kevin Gorman , President and CEO of Neurocrine ... Jaffray Healthcare Conference in New York ... encouraged to visit the website approximately 5 minutes prior ... software.  A replay of the presentation will be available ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)... November 24, 2015 --> ... research report "Oligonucleotide Synthesis Market by Product & Services ... Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, ... MarketsandMarkets, the market is expected to reach USD 1,918.6 ... at a CAGR of 10.1% during the forecast period. ...
Breaking Biology Technology: